Chris O'BrienUnclaimed
Host of Few & Far Between: How Biotech Gets Built.
Host, Few & Far Between: How Biotech Gets Built
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
About
Chris hosts Few & Far Between: How Biotech Gets Built.
Written by PodSubs from Chris's credits.
PodCred record
PodCred is the verified record of where Chris has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Chris on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Chris claims this profile.
Recommendations
No recommendations for Chris yet.
Recommendations open once Chris claims the profile.
Recent episodes
From the shows they work on now
Episode 75: Joanne Kamens, CEO of Women in Bio
Few & Far Between: How Biotech Gets Built
We're kicking off a new season of the Biorasi Few & Far Between podcast - and we'll be focusing on how today’s women leaders are navigating the future of biotech. Join Host Melissa Alesse as she welcomes Joanne Kamens,...
Episode 74: Jason Tardio, President and COO, Immunic Therapeutics
Few & Far Between: How Biotech Gets Built
Today on the Biorasi Few & Far Between Podcast: Host Melissa Alesse welcomes Jason Tardio, President and COO of Immunic Therapeutics, to the podcast to explore the biotech journey to R&D and commercialization. We'll...
Episode 73: Isaac Stoner, CEO, MindImmune Therapeutics, Inc.
Few & Far Between: How Biotech Gets Built
Today on the Biorasi Few & Far Between podcast: Host Melissa Alesse welcomes Isaac Stoner, CEO of MindImmune Therapeutics, back to the podcast for a conversation on the evolving science of Alzheimer's disease and the...
Episode 72: Joel White, Owner, Marketcap Consulting
Few & Far Between: How Biotech Gets Built
Today on the Biorasi Few & Far Between podcast: What's trending in the CRO market? Find out as host Melissa Alesse welcomes Joel White, owner of Marketcap Consulting and 20+ year veteran of the CRO industry. We'll...
Episode 71: Chris O'Brien, Former Biorasi CEO and Current CEO of Rancho Biosciences
Few & Far Between: How Biotech Gets Built
Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences and Biorasi Board member - as they explore the origins and evolution of our podcast...
Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School
Few & Far Between: How Biotech Gets Built
Today on the Biorasi podcast, we look back on three years of AI innovation in healthcare and clinical trials - breaking new boundaries and a creating a new reality across all industries. Host Chris O'Brien welcomes back...
Video Episode 68: Sinan Gölhan, CEO at GelTech Labs
Few & Far Between: How Biotech Gets Built
How do today’s CEOs and founders find the balance between planning and entrepreneurship? Check out the latest episode of the Biorasi Few & Far Between podcast - How Biotech Gets Built. Host Chris O'Brien welcomes Sinan...
Video Episode 67: Aoife Brennan, President and CEO of Climb Bio
Few & Far Between: How Biotech Gets Built
Let's kick off 2026 with the first Biorasi podcast episode of the year! How do you get "Biotech Vision" to see the complete picture of your place in the industry? Find out in the latest episode of the Few & Far Between...
Episode 66: Mark Abelson, Founder of Ora Clinical
Few & Far Between: How Biotech Gets Built
Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora Clinical and CRO pioneer. We'll be...
Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience
Few & Far Between: How Biotech Gets Built
With biotech, is it the destination, the journey, or both? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Amit Etkin, Founder and CEO of Alto Neuroscience and...
